Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | CA7 | P43166 | 1/20 | 0.35 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6325095 | 0.97 | — | — | |
| SCHEMBL28751819 | 0.78 | EPAS1 (0.37) | CA1CA2 | |
| SCHEMBL758884 | 0.69 | CA2 (0.41) | CA1CA2CA7CA13 | |
| SCHEMBL160 | 0.69 | CA2 (0.41) | CA1CA2CA7CA13 | |
| SCHEMBL758883 | 0.69 | CA2 (0.41) | CA1CA2CA7CA13 | |
| SCHEMBL2085247 | 0.69 | CA2 (0.41) | CA1CA2CA7CA13 | |
| SCHEMBL2159907 | 0.67 | — | — | |
| SCHEMBL4606069 | 0.67 | CA2 (0.44) | CA1CA2 | |
| SCHEMBL16893283 | 0.67 | — | — | |
| SCHEMBL6830251 | 0.67 | CA2 (0.39) | CA1CA2CA7CA13 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11607464-B2 | Compositions and methods for the treatment and imaging of cancer | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA (US) | 2023-03-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11607464-B2 | Compositions and methods for the treatment and imaging of cancer | TP53, CA13, CA14 | CA1 216/4885CA2 761/4885CA7 15/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.